Mitochondrial Dysfunction Assays

Mitochondrial Dysfunction Assays is a methodological framework that quantifies impairments in mitochondrial physiology, particularly in membrane potential, reactive oxygen species production, and adenosine triphosphate synthesis, to evaluate cellular toxicity and metabolic stress.

331

Publications

15.7K

Citations

2K

Authors

644

Institutions

Publications per year

2017–2026

158

Authors

2K

  1. YW
    Yvonne Will

    Pfizer (United States), United States

    7 publications · 574 citations

    7

    h-index

  2. SN
    Sashi Nadanaciva

    Pfizer (United States), United States

    5 publications · 370 citations

    5

    h-index

  3. RC
    Roderick Capaldi

    University of Oregon, United States

    5 publications · 233 citations

    5

    h-index

  4. DH
    David H. Jang

    University of Pennsylvania, United States

    4 publications · 100 citations

    4

    h-index

  5. JN
    Joel N. Meyer

    Duke University, United States

    4 publications · 286 citations

    4

    h-index

1–5 of 2K

Venues

  1. PubMed

    Repository · 16 publications · 567 citations

    15

    h-index

  2. PLoS ONE

    9 publications · 623 citations

    9

    h-index

  3. Methods in molecular biology

    Book series · 8 publications · 196 citations

    8

    h-index

  4. Toxicology in Vitro

    7 publications · 553 citations

    7

    h-index

  5. Investigative Ophthalmology & Visual Science

    IOVS · 7 publications · 542 citations

    7

    h-index

1–5